dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1468881067
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr14:103466354 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- G>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
- T=0.000004 (1/248824, GnomAD_exome)
- Clinical Significance
- Not Reported in ClinVar
- Gene : Consequence
- MARK3 : Missense Variant
- Publications
- 0 citations
- Genomic View
- See rs on genome
Help
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| gnomAD - Exomes | Global | Study-wide | 248824 | G=0.999996 | T=0.000004 |
| gnomAD - Exomes | European | Sub | 134474 | G=1.000000 | T=0.000000 |
| gnomAD - Exomes | Asian | Sub | 48466 | G=0.99998 | T=0.00002 |
| gnomAD - Exomes | American | Sub | 34320 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | African | Sub | 15464 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | Ashkenazi Jewish | Sub | 10054 | G=1.00000 | T=0.00000 |
| gnomAD - Exomes | Other | Sub | 6046 | G=1.0000 | T=0.0000 |
Help
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Genomic Placements
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 14 | NC_000014.9:g.103466354G>T |
| GRCh37.p13 chr 14 | NC_000014.8:g.103932691G>T |
| MARK3 RefSeqGene | NG_030339.2:g.85991G>T |
Gene: MARK3, microtubule affinity regulating kinase 3
(plus strand)
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| MARK3 transcript variant 1 | NM_001128918.3:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform a | NP_001122390.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant 5 | NM_001128921.3:c.672G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform e | NP_001122393.2:p.Lys224Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant 3 | NM_002376.7:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform c | NP_002367.5:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant 4 | NM_001128920.3:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform d | NP_001122392.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant 2 | NM_001128919.3:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform b | NP_001122391.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X1 | XM_047431377.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X1 | XP_047287333.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X2 | XM_005267641.6:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X2 | XP_005267698.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X3 | XM_005267642.6:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X3 | XP_005267699.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X4 | XM_047431378.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X4 | XP_047287334.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X5 | XM_047431379.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X5 | XP_047287335.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X6 | XM_017021291.3:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X6 | XP_016876780.1:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X7 | XM_047431380.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X7 | XP_047287336.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X7 | XM_047431381.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X7 | XP_047287337.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X8 | XM_017021292.3:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X8 | XP_016876781.1:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X9 | XM_047431382.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X9 | XP_047287338.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X10 | XM_047431383.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X10 | XP_047287339.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X11 | XM_047431384.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X11 | XP_047287340.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X12 | XM_047431385.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X12 | XP_047287341.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X13 | XM_047431386.1:c.813G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X13 | XP_047287342.1:p.Lys271Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X14 | XM_047431387.1:c.867G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X14 | XP_047287343.1:p.Lys289Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X15 | XM_047431388.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X15 | XP_047287344.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X16 | XM_017021294.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X16 | XP_016876783.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X17 | XM_017021295.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X17 | XP_016876784.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X19 | XM_017021296.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X19 | XP_016876785.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X18 | XM_017021297.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X18 | XP_016876786.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X19 | XM_011536769.4:c.669G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X19 | XP_011535071.1:p.Lys223Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X20 | XM_017021298.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X20 | XP_016876787.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X21 | XM_017021299.3:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X21 | XP_016876788.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X22 | XM_047431389.1:c.669G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X22 | XP_047287345.1:p.Lys223Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X23 | XM_047431390.1:c.717G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X23 | XP_047287346.1:p.Lys239Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X24 | XM_005267643.6:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X24 | XP_005267700.2:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X25 | XM_047431391.1:c.909G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X25 | XP_047287347.1:p.Lys303Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X26 | XM_047431392.1:c.855G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X26 | XP_047287348.1:p.Lys285Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X27 | XM_017021301.3:c.516G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X27 | XP_016876790.1:p.Lys172Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X28 | XM_047431393.1:c.438G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X28 | XP_047287349.1:p.Lys146Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X29 | XM_047431394.1:c.438G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X28 | XP_047287350.1:p.Lys146Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X30 | XM_047431395.1:c.438G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X29 | XP_047287351.1:p.Lys146Asn | K (Lys) > N (Asn) | Missense Variant |
| MARK3 transcript variant X31 | XM_047431396.1:c.438G>T | K [AAG] > N [AAT] | Coding Sequence Variant |
| MAP/microtubule affinity-regulating kinase 3 isoform X30 | XP_047287352.1:p.Lys146Asn | K (Lys) > N (Asn) | Missense Variant |
Help
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Not Reported in ClinVar
Help
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | G= | T |
|---|---|---|
| GRCh38.p14 chr 14 | NC_000014.9:g.103466354= | NC_000014.9:g.103466354G>T |
| GRCh37.p13 chr 14 | NC_000014.8:g.103932691= | NC_000014.8:g.103932691G>T |
| MARK3 RefSeqGene | NG_030339.2:g.85991= | NG_030339.2:g.85991G>T |
| MARK3 transcript variant 3 | NM_002376.7:c.909= | NM_002376.7:c.909G>T |
| MARK3 transcript variant 3 | NM_002376.6:c.909= | NM_002376.6:c.909G>T |
| MARK3 transcript variant 3 | NM_002376.5:c.909= | NM_002376.5:c.909G>T |
| MARK3 transcript variant 1 | NM_001128918.3:c.909= | NM_001128918.3:c.909G>T |
| MARK3 transcript variant 1 | NM_001128918.2:c.909= | NM_001128918.2:c.909G>T |
| MARK3 transcript variant 1 | NM_001128918.1:c.909= | NM_001128918.1:c.909G>T |
| MARK3 transcript variant 2 | NM_001128919.3:c.909= | NM_001128919.3:c.909G>T |
| MARK3 transcript variant 2 | NM_001128919.2:c.909= | NM_001128919.2:c.909G>T |
| MARK3 transcript variant 2 | NM_001128919.1:c.909= | NM_001128919.1:c.909G>T |
| MARK3 transcript variant 4 | NM_001128920.3:c.909= | NM_001128920.3:c.909G>T |
| MARK3 transcript variant 4 | NM_001128920.2:c.909= | NM_001128920.2:c.909G>T |
| MARK3 transcript variant 4 | NM_001128920.1:c.909= | NM_001128920.1:c.909G>T |
| MARK3 transcript variant 5 | NM_001128921.3:c.672= | NM_001128921.3:c.672G>T |
| MARK3 transcript variant 5 | NM_001128921.2:c.672= | NM_001128921.2:c.672G>T |
| MARK3 transcript variant 5 | NM_001128921.1:c.672= | NM_001128921.1:c.672G>T |
| MARK3 transcript variant 6 | NM_001411055.1:c.855= | NM_001411055.1:c.855G>T |
| MARK3 transcript variant 7 | NM_001411056.1:c.717= | NM_001411056.1:c.717G>T |
| MARK3 transcript variant X2 | XM_005267641.6:c.909= | XM_005267641.6:c.909G>T |
| MARK3 transcript variant X2 | XM_005267641.5:c.909= | XM_005267641.5:c.909G>T |
| MARK3 transcript variant X2 | XM_005267641.4:c.909= | XM_005267641.4:c.909G>T |
| MARK3 transcript variant X2 | XM_005267641.3:c.909= | XM_005267641.3:c.909G>T |
| MARK3 transcript variant X2 | XM_005267641.2:c.909= | XM_005267641.2:c.909G>T |
| MARK3 transcript variant X2 | XM_005267641.1:c.909= | XM_005267641.1:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.6:c.909= | XM_005267642.6:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.5:c.909= | XM_005267642.5:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.4:c.909= | XM_005267642.4:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.3:c.909= | XM_005267642.3:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.2:c.909= | XM_005267642.2:c.909G>T |
| MARK3 transcript variant X3 | XM_005267642.1:c.909= | XM_005267642.1:c.909G>T |
| MARK3 transcript variant X24 | XM_005267643.6:c.909= | XM_005267643.6:c.909G>T |
| MARK3 transcript variant X14 | XM_005267643.5:c.909= | XM_005267643.5:c.909G>T |
| MARK3 transcript variant X14 | XM_005267643.4:c.909= | XM_005267643.4:c.909G>T |
| MARK3 transcript variant X7 | XM_005267643.3:c.909= | XM_005267643.3:c.909G>T |
| MARK3 transcript variant X4 | XM_005267643.2:c.909= | XM_005267643.2:c.909G>T |
| MARK3 transcript variant X4 | XM_005267643.1:c.909= | XM_005267643.1:c.909G>T |
| MARK3 transcript variant X19 | XM_011536769.4:c.669= | XM_011536769.4:c.669G>T |
| MARK3 transcript variant X10 | XM_011536769.3:c.669= | XM_011536769.3:c.669G>T |
| MARK3 transcript variant X10 | XM_011536769.2:c.669= | XM_011536769.2:c.669G>T |
| MARK3 transcript variant X5 | XM_011536769.1:c.669= | XM_011536769.1:c.669G>T |
| MARK3 transcript variant X6 | XM_017021291.3:c.909= | XM_017021291.3:c.909G>T |
| MARK3 transcript variant X4 | XM_017021291.2:c.909= | XM_017021291.2:c.909G>T |
| MARK3 transcript variant X4 | XM_017021291.1:c.909= | XM_017021291.1:c.909G>T |
| MARK3 transcript variant X8 | XM_017021292.3:c.909= | XM_017021292.3:c.909G>T |
| MARK3 transcript variant X5 | XM_017021292.2:c.909= | XM_017021292.2:c.909G>T |
| MARK3 transcript variant X5 | XM_017021292.1:c.909= | XM_017021292.1:c.909G>T |
| MARK3 transcript variant X16 | XM_017021294.3:c.717= | XM_017021294.3:c.717G>T |
| MARK3 transcript variant X7 | XM_017021294.2:c.717= | XM_017021294.2:c.717G>T |
| MARK3 transcript variant X7 | XM_017021294.1:c.717= | XM_017021294.1:c.717G>T |
| MARK3 transcript variant X17 | XM_017021295.3:c.717= | XM_017021295.3:c.717G>T |
| MARK3 transcript variant X8 | XM_017021295.2:c.717= | XM_017021295.2:c.717G>T |
| MARK3 transcript variant X8 | XM_017021295.1:c.717= | XM_017021295.1:c.717G>T |
| MARK3 transcript variant X19 | XM_017021296.3:c.717= | XM_017021296.3:c.717G>T |
| MARK3 transcript variant X18 | XM_017021297.3:c.717= | XM_017021297.3:c.717G>T |
| MARK3 transcript variant X11 | XM_017021297.2:c.717= | XM_017021297.2:c.717G>T |
| MARK3 transcript variant X11 | XM_017021297.1:c.717= | XM_017021297.1:c.717G>T |
| MARK3 transcript variant X27 | XM_017021301.3:c.516= | XM_017021301.3:c.516G>T |
| MARK3 transcript variant X16 | XM_017021301.2:c.516= | XM_017021301.2:c.516G>T |
| MARK3 transcript variant X16 | XM_017021301.1:c.516= | XM_017021301.1:c.516G>T |
| MARK3 transcript variant X20 | XM_017021298.3:c.717= | XM_017021298.3:c.717G>T |
| MARK3 transcript variant X12 | XM_017021298.2:c.717= | XM_017021298.2:c.717G>T |
| MARK3 transcript variant X12 | XM_017021298.1:c.717= | XM_017021298.1:c.717G>T |
| MARK3 transcript variant X21 | XM_017021299.3:c.717= | XM_017021299.3:c.717G>T |
| MARK3 transcript variant X13 | XM_017021299.2:c.717= | XM_017021299.2:c.717G>T |
| MARK3 transcript variant X13 | XM_017021299.1:c.717= | XM_017021299.1:c.717G>T |
| MARK3 transcript variant X4 | XM_047431378.1:c.855= | XM_047431378.1:c.855G>T |
| MARK3 transcript variant X7 | XM_047431380.1:c.855= | XM_047431380.1:c.855G>T |
| MARK3 transcript variant X9 | XM_047431382.1:c.855= | XM_047431382.1:c.855G>T |
| MARK3 transcript variant X11 | XM_047431384.1:c.855= | XM_047431384.1:c.855G>T |
| MARK3 transcript variant X15 | XM_047431388.1:c.855= | XM_047431388.1:c.855G>T |
| MARK3 transcript variant X23 | XM_047431390.1:c.717= | XM_047431390.1:c.717G>T |
| MARK3 transcript variant X25 | XM_047431391.1:c.909= | XM_047431391.1:c.909G>T |
| MARK3 transcript variant X26 | XM_047431392.1:c.855= | XM_047431392.1:c.855G>T |
| MARK3 transcript variant X7 | XM_047431381.1:c.867= | XM_047431381.1:c.867G>T |
| MARK3 transcript variant X12 | XM_047431385.1:c.867= | XM_047431385.1:c.867G>T |
| MARK3 transcript variant X13 | XM_047431386.1:c.813= | XM_047431386.1:c.813G>T |
| MARK3 transcript variant X1 | XM_047431377.1:c.867= | XM_047431377.1:c.867G>T |
| MARK3 transcript variant X5 | XM_047431379.1:c.867= | XM_047431379.1:c.867G>T |
| MARK3 transcript variant X10 | XM_047431383.1:c.867= | XM_047431383.1:c.867G>T |
| MARK3 transcript variant X14 | XM_047431387.1:c.867= | XM_047431387.1:c.867G>T |
| MARK3 transcript variant X22 | XM_047431389.1:c.669= | XM_047431389.1:c.669G>T |
| MARK3 transcript variant X28 | XM_047431393.1:c.438= | XM_047431393.1:c.438G>T |
| MARK3 transcript variant X29 | XM_047431394.1:c.438= | XM_047431394.1:c.438G>T |
| MARK3 transcript variant X30 | XM_047431395.1:c.438= | XM_047431395.1:c.438G>T |
| MARK3 transcript variant X31 | XM_047431396.1:c.438= | XM_047431396.1:c.438G>T |
| MAP/microtubule affinity-regulating kinase 3 isoform c | NP_002367.5:p.Lys303= | NP_002367.5:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform a | NP_001122390.2:p.Lys303= | NP_001122390.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform b | NP_001122391.2:p.Lys303= | NP_001122391.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform d | NP_001122392.2:p.Lys303= | NP_001122392.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform e | NP_001122393.2:p.Lys224= | NP_001122393.2:p.Lys224Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X2 | XP_005267698.2:p.Lys303= | XP_005267698.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X3 | XP_005267699.2:p.Lys303= | XP_005267699.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X24 | XP_005267700.2:p.Lys303= | XP_005267700.2:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X19 | XP_011535071.1:p.Lys223= | XP_011535071.1:p.Lys223Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X6 | XP_016876780.1:p.Lys303= | XP_016876780.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X8 | XP_016876781.1:p.Lys303= | XP_016876781.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X16 | XP_016876783.1:p.Lys239= | XP_016876783.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X17 | XP_016876784.1:p.Lys239= | XP_016876784.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X19 | XP_016876785.1:p.Lys239= | XP_016876785.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X18 | XP_016876786.1:p.Lys239= | XP_016876786.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X27 | XP_016876790.1:p.Lys172= | XP_016876790.1:p.Lys172Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X20 | XP_016876787.1:p.Lys239= | XP_016876787.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X21 | XP_016876788.1:p.Lys239= | XP_016876788.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X4 | XP_047287334.1:p.Lys285= | XP_047287334.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X7 | XP_047287336.1:p.Lys285= | XP_047287336.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X9 | XP_047287338.1:p.Lys285= | XP_047287338.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X11 | XP_047287340.1:p.Lys285= | XP_047287340.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X15 | XP_047287344.1:p.Lys285= | XP_047287344.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X23 | XP_047287346.1:p.Lys239= | XP_047287346.1:p.Lys239Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X25 | XP_047287347.1:p.Lys303= | XP_047287347.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X26 | XP_047287348.1:p.Lys285= | XP_047287348.1:p.Lys285Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X7 | XP_047287337.1:p.Lys289= | XP_047287337.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X12 | XP_047287341.1:p.Lys289= | XP_047287341.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X13 | XP_047287342.1:p.Lys271= | XP_047287342.1:p.Lys271Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X1 | XP_047287333.1:p.Lys289= | XP_047287333.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X5 | XP_047287335.1:p.Lys289= | XP_047287335.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X10 | XP_047287339.1:p.Lys289= | XP_047287339.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X14 | XP_047287343.1:p.Lys289= | XP_047287343.1:p.Lys289Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X22 | XP_047287345.1:p.Lys223= | XP_047287345.1:p.Lys223Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X28 | XP_047287349.1:p.Lys146= | XP_047287349.1:p.Lys146Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X28 | XP_047287350.1:p.Lys146= | XP_047287350.1:p.Lys146Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X29 | XP_047287351.1:p.Lys146= | XP_047287351.1:p.Lys146Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X30 | XP_047287352.1:p.Lys146= | XP_047287352.1:p.Lys146Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform a | NP_001122390.1:p.Lys303= | NP_001122390.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform b | NP_001122391.1:p.Lys303= | NP_001122391.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform d | NP_001122392.1:p.Lys303= | NP_001122392.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform e | NP_001122393.1:p.Lys224= | NP_001122393.1:p.Lys224Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform c | NP_002367.4:p.Lys303= | NP_002367.4:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X2 | XP_005267698.1:p.Lys303= | XP_005267698.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X3 | XP_005267699.1:p.Lys303= | XP_005267699.1:p.Lys303Asn |
| MAP/microtubule affinity-regulating kinase 3 isoform X4 | XP_005267700.1:p.Lys303= | XP_005267700.1:p.Lys303Asn |
Help
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
1 SubSNP,
1 Frequency
submissions
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | GNOMAD | ss2740971560 | Nov 08, 2017 (151) |
| 2 | gnomAD - Exomes | NC_000014.8 - 103932691 | Jul 13, 2019 (153) |
Help
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Help
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
No publications for rs1468881067
Help
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genome context:
Select flank length:
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.